2006 Book Chapter Primary mineralocorticoid excess syndromesEdwards, Christopher R. W. and Stowasser, Michael (2006). Primary mineralocorticoid excess syndromes. Endocrinology. (pp. 2461-2490) edited by L. J. DeGroot and J. L. Jameson. USA: Elsevier Saunders. |
2006 Conference Publication No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type IISo, A., Jeske, Y., Gordon, R. D., Duffy, D., Kelemen, L. and Stowasser, M. (2006). No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15 to 19 October 2006. Japan: International Society of Hypertension. |
2006 Conference Publication Prevalence of primary aldosteronism among Chinese hypertensive patientsGong, Y., Zhu, D., Zhang,, Chen, S. L., Chu, S.X., Zhang, L.H., Stowasser, M. and Gordon, R. D. (2006). Prevalence of primary aldosteronism among Chinese hypertensive patients. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15th to 19th October, 2006. Japan: International Society of Hypertension. |
2006 Conference Publication Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronismKostner, K., Liu, Y., Cowley, D. and Stowasser, M. (2006). Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism. ISA 2006: XIV International Symposium on Atherosclerosis, Rome, Italy, 18-22 June 2006. E. Park, Shannon, Co. Clare, Ireland: Elsevier Ireland. doi: 10.1016/S1567-5688(06)81883-0 |
2006 Book Chapter The hypertensive accountantStowasser, Michael and Gordon, Richard D. (2006). The hypertensive accountant. Tietz's applied laboratory medicine. (pp. 175-182) edited by G. M. Scott, A. M. Gronowski, C. S. Eby and N. W. Tietz. Hoboken, N.J.: Wiley-Interscience. doi: 10.1002/9780470086087.ch23 |
2005 Journal Article Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type IStowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard D., Ward, Gregory, Cowley, Diane and Marwick, Thomas H. (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. Journal of Clinical Endocrinology and Metabolism, 90 (9), 5070-5076. doi: 10.1210/jc.2005-0681 |
2005 Journal Article Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneitySo, A, Duffy, DL, Gordon, RD, Jeske, YWA, Lin-Su, K, New, MI and Stowasser, M (2005). Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. Journal of Hypertension, 23 (8), 1477-1484. doi: 10.1097/01.hjh.0000174299.66369.26 |
2005 Conference Publication Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindredStowasser, M, Elphinstone, M, So, A, Jeske, Y and Gordon, R (2005). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. 26th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, Sydney Australia, Nov 24-26, 2004. OXFORD: BLACKWELL PUBLISHING. |
2005 Journal Article Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressureSharman, James E., Fang, Zhi Y., Haluska, Brian, Stowasser, Michael, Prins, Johannes B. and Marwick, Thomas H. (2005). Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care, 28 (4), 937-939. doi: 10.2337/diacare.28.4.937 |
2005 Conference Publication Further evidence of linkage at 7p22 with familial hyperaldosteronism type IISo, Albertina, Stowasser, Michael, Gordon, Richard, Duffy, David and Jeske, Yvette (2005). Further evidence of linkage at 7p22 with familial hyperaldosteronism type II. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, USA, 14-18 May 2005. Elsevier Inc: New York, USA. doi: 10.1016/j.amjhyper.2005.03.659 |
2005 Book Chapter Overview of mineralocorticoid excess syndromesGordon, Richard D. and Stowasser, Michael (2005). Overview of mineralocorticoid excess syndromes. Adrenal glands: Diagnostic aspects and surgical therapy. (pp. 115-126) edited by Dimitrios Linos and Jon A. van Heerden. Berlin: Springer. |
2005 Conference Publication Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversionStowasser, M, Jeske, Y., So, A., Gordon, R. and Duffy, D. (2005). Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Oxford: Blackwell Scientific Publications. |
2005 Conference Publication No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sampleJeske, Y., So, A., Gordon, R. D., Duffy, D. and Stowasser, M. (2005). No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, U.S.A., 14-18 May 2005. New York, U.S.A.: Nature Publishing Group. doi: 10.1016/j.amjhyper.2005.03.012 |
2005 Conference Publication Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneitySo, A., Stowasser, M., Gordon, R., Duffy, D. and Jeske, Y. (2005). Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Blackwell Scientific Publications: BLACKWELL PUBLISHING. |
2005 Conference Publication Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type IStowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard, Ward, Gregory, Cowley, Diane and Marwick, Thomas (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, CA, USA, 14 - 18 May, 2005. USA: Elsevier Inc. doi: 10.1016/j.amjhyper.2005.03.648 |
2004 Journal Article Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindredElphinstone, Martin S., Gordon, Richard D., So, Albertina, Jeske, Yvette W. A., Stratakis, Constantine A. and Stowasser, Michael (2004). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clinical Endocrinology, 61 (6), 716-723. doi: 10.1111/j.1365-2265.2004.02155.x |
2004 Journal Article The aldosterone-renin ratio in screening for primary aldosteronismStowasser, Michael and Gordon, Richard D. (2004). The aldosterone-renin ratio in screening for primary aldosteronism. Endocrinologist, 14 (5), 267-276. doi: 10.1097/01.ten.0000139006.29471.9e |
2004 Conference Publication Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonismMottram, PM, Haluska, BA, Leano, R, Cowley, D, Stowasser, M and Marwick, TH (2004). Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism. ESC Congress 2004, Munich Germany, Aug 28-Sep 01, 2004. |
2004 Conference Publication Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continentsMulatero, P, Stowasser, M, Loh, KC, Fardella, CE, Gordon, RD, Mosso, L, Gomez-Sanchez, CE, Veglio, F and Young, WF (2004). Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. 14th European Meeting on Hypertension, Paris France, Jun 13-17, 2004. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00004872-200406002-00629 |
2004 Conference Publication Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?Stowasser, M, Mottram, P, Leano, R, Klaassen, P, Cowley, D and Marwick, T (2004). Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?. 30th International Geographical Congress 2004, Glasgow Scotland, Aug, 2004. CARLTON: LIPPINCOTT WILLIAMS & WILKINS. |